AA
GSK icon

Addison Advisors’s GSK GSK Stock Holding History

Addison Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.7K Sell
967
-3,241
-77% -$171K 0.02% 248
2026
Q1 		$232K Sell
4,208
-44
-1% -$2.38K 0.05% 204
2025
Q4 		$209K Sell
4,252
-750
-15% -$35K 0.05% 212
2025
Q3 		$216K Sell
5,002
-441
-8% -$17.2K 0.05% 213
2025
Q2 		$209K Buy
5,443
+734
+16% +$28K 0.05% 213
2025
Q1 		$182K Buy
4,709
+411
+10% +$15K 0.05% 220
2024
Q4 		$145K Buy
4,298
+266
+7% +$9.58K 0.04% 251
2024
Q3 		$165K Buy
4,032
+253
+7% +$10.3K 0.05% 244
2024
Q2 		$145K Buy
3,779
+67
+2% +$2.82K 0.05% 244
2024
Q1 		$159K Buy
3,712
+10
+0.3% +$412 0.05% 224
2023
Q4 		$137K Buy
3,702
+395
+12% +$14.2K 0.05% 235
2023
Q3 		$120K Buy
3,307
+432
+15% +$15.3K 0.06% 224
2023
Q2 		$102K Buy
2,875
+314
+12% +$11.3K 0.05% 242
2023
Q1 		$91.1K Sell
2,561
-7
-0.3% -$245 0.05% 236
2022
Q4 		$90.2K Buy
2,568
+2,152
+517% +$71.7K 0.05% 227
2022
Q3 		$12K Buy
+416
New +$15.8K 0.01% 423
2022
Q2 		– Sell
-1,510
Closed -$82K – 709
2022
Q1 		$82K Buy
1,510
+1,243
+466% +$67.5K 0.04% 226
2021
Q4 		$15K Buy
267
+135
+102% +$7.02K 0.01% 371
2021
Q3 		$6K Sell
132
-181
-58% -$9.09K ﹤0.01% 339
2021
Q2 		$16K Buy
+313
New +$15K 0.01% 272
2020
Q4 		$16K Buy
+345
New +$15.8K 0.02% 258

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Addison Advisors's GSK Position: Q2 2026 in Review

Addison Advisors reduced its GSK (GSK) stake by 77% in Q2 2026, selling an estimated $171K and leaving 967 shares worth $50.7K. The position accounts for 0.02% of the portfolio, ranked #248.

Addison Advisors first reported a position in GSK in Q4 2020 and has held it in 21 quarters since. The position peaked at $232K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Addison Advisors held 967 shares of GSK worth $50.7K as of Q2 2026.
  • Addison Advisors sold 3,241 GSK shares in Q2 2026, an estimated $171K.
  • GSK made up 0.02% of Addison Advisors's portfolio in Q2 2026, its #248 holding.
  • Addison Advisors first reported a position in GSK in Q4 2020 and has held it in 21 quarters since.
  • Addison Advisors's GSK position peaked at $232K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.